{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:23:42Z","timestamp":1794893022695,"version":"4.9.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["P50DK096418"],"award-info":[{"award-number":["P50DK096418"]}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.blre.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T20:34:23Z","timestamp":1417293263000},"page":"191-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":323,"title":["A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury"],"prefix":"10.1016","volume":"29","author":[{"given":"Sonata","family":"Jodele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Laskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"El-Bietar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley P.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2014.11.001_bb0005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2014.11.001_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bmt.1705599","article-title":"Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival","volume":"39","author":"Kersting","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0015","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1523-1755.2005.00301.x","article-title":"Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant","volume":"67","author":"Parikh","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.blre.2014.11.001_bb0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.11.001_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-010-1637-4","article-title":"Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy","volume":"26","author":"Keir","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2012.09.006","article-title":"Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome","volume":"126","author":"Tsai","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0040","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.11.001_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0050","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/bmt.2014.40","article-title":"Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy","volume":"49","author":"Lerner","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bmt.2008.419","article-title":"Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy","volume":"44","author":"Inamoto","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0060","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","article-title":"Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation","volume":"16","author":"Glezerman","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0070","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbmt.2012.06.006","article-title":"Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation","volume":"18","author":"Laskin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0075","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bmt.2010.182","article-title":"Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT","volume":"46","author":"Laskin","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0080","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00467-006-0358-1","article-title":"Glomerular filtration rate measurement and estimation in chronic kidney disease","volume":"22","author":"Schwartz","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-012-2341-3","article-title":"Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury","volume":"28","author":"Nehus","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bmt.2013.197","article-title":"Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease","volume":"49","author":"Hingorani","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbmt.2008.09.015","article-title":"Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival","volume":"14","author":"Hingorani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0110","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.11.001_bb0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.blre.2014.11.001_bb0120","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00467-011-1928-4","article-title":"Glucocorticoid-induced hypertension","volume":"27","author":"Goodwin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1667\/RR2400.1","article-title":"Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation","volume":"175","author":"Moulder","year":"2011","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2014.11.001_bb0130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00467-008-0785-2","article-title":"Chronic kidney disease after liver, cardiac, lung, heart\u2013lung, and hematopoietic stem cell transplant","volume":"23","author":"Hingorani","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0135","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbmt.2011.02.012","article-title":"Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation","volume":"17","author":"Haines","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.blre.2014.11.001_bb0140","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbmt.2009.04.016","article-title":"BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants","volume":"15","author":"O'Donnell","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2014.11.001_bb0150","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0155","doi-asserted-by":"crossref","first-page":"845864","DOI":"10.1155\/2011\/845864","article-title":"Diagnosis and management of pulmonary arterial hypertension","volume":"2011","author":"Houtchens","year":"2011","journal-title":"Pulm Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.transproceed.2005.12.040","article-title":"Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report","volume":"38","author":"Perkowska-Ptasinska","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.blre.2014.11.001_bb0165","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","author":"Rabinovitch","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2014.11.001_bb0170","article-title":"Abnormal echocardiography seven days after stem cell transplant may be an early indicator of thrombotic microangiopathy","author":"Dandoy","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.echo.2010.01.003","article-title":"Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics","volume":"23","author":"Milan","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.blre.2014.11.001_bb0180","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.blre.2014.11.001_bb0185","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1016\/j.transproceed.2010.08.025","article-title":"Late-onset intestinal perforation in the setting of posttransplantation microangiopathy: a case report","volume":"42","author":"Aljitawi","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.blre.2014.11.001_bb0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0609.2009.01267.x","article-title":"Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy","volume":"83","author":"Hewamana","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0195","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bmt.1705099","article-title":"Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation","volume":"36","author":"Narimatsu","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0200","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704512","article-title":"Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease","volume":"33","author":"Nishida","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1620\/tjem.227.31","article-title":"Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"227","author":"Yamada-Fujiwara","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bmt.1705588","article-title":"Intestinal thrombotic microangiopathy induced by FK506 in rats","volume":"39","author":"Fujino","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0215","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1100\/tsw.2009.115","article-title":"Unusual case report of thrombotic microangiopathy of the small bowel following liver transplantation, a possible immunosuppressant-induced disease with histological and ultrastructural findings","volume":"9","author":"Piscitelli","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.blre.2014.11.001_bb0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.transproceed.2009.12.016","article-title":"Thrombotic microangiopathy following intestinal transplantation: a single center experience","volume":"42","author":"Dierickx","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.blre.2014.11.001_bb0225","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.bmt.1705160","article-title":"Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants","volume":"36","author":"Martinez","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0885066610393634","article-title":"Posterior reversible encephalopathy syndrome","volume":"27","author":"Staykov","year":"2012","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0240","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/practneurol-2011-000010","article-title":"The posterior reversible encephalopathy syndrome: what's certain, what's new?","volume":"11","author":"Roth","year":"2011","journal-title":"Pract Neurol"},{"key":"10.1016\/j.blre.2014.11.001_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10157-010-0376-y","article-title":"Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease","volume":"15","author":"Ishikawa","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0250","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/petr.12062","article-title":"Pericardial effusion after pediatric hematopoietic cell transplant","volume":"17","author":"Aldoss","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0255","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/bmt.2010.297","article-title":"Large pericardial effusion as a complication in adults undergoing SCT","volume":"46","author":"Norkin","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ndt\/gfn649","article-title":"Cardiac tamponade in diarrhoea-positive haemolytic uraemic syndrome","volume":"24","author":"Mohammed","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4330\/wjc.v3.i5.135","article-title":"Diagnosis and management of pericardial effusion","volume":"3","author":"Sagrista-Sauleda","year":"2011","journal-title":"World J Cardiol"},{"key":"10.1016\/j.blre.2014.11.001_bb0270","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","article-title":"Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kojouri","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.blre.2014.11.001_bb0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0285","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","article-title":"Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children","volume":"11","author":"Hale","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.blre.2014.11.001_bb0295","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pbc.22861","article-title":"Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus","volume":"57","author":"Rosenthal","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.11.001_bb0305","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","article-title":"A phase II pilot study of tacrolimus\/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens","volume":"115","author":"Rodriguez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.11.001_bb0310","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2008.11.004","article-title":"Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial","volume":"15","author":"Platzbecker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0325","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u2018novel\u2019 target of graft-versus-host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0335","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0340","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bmt.1702517","article-title":"Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome","volume":"26","author":"Takatsuka","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0345","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2141.2007.06515.x","article-title":"Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem-cell transplantation for myelodysplastic syndrome","volume":"136","author":"Nakamura","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0350","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0355","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2215\/CJN.01700407","article-title":"Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature","volume":"2","author":"Chang","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3062.2010.00581.x","article-title":"BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient","volume":"13","author":"Lopes da Silva","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2014.11.001_bb0365","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2014.11.001_bb0370","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.blre.2014.11.001_bb0375","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2014.17","article-title":"Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus","volume":"49","author":"Labrador","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0380","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2014.11.001_bb0390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1440-1827.2010.02608.x","article-title":"Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"key":"10.1016\/j.blre.2014.11.001_bb0395","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1827.2011.02704.x","article-title":"Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"key":"10.1016\/j.blre.2014.11.001_bb0400","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/bmt.2012.120","article-title":"Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?","volume":"48","author":"Sadeghi","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0410","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.11.001_bb0420","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.blre.2014.11.001_bb0425","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.11.001_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.2006.06126.x","article-title":"Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation","volume":"134","author":"Peyvandi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0435","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0440","doi-asserted-by":"crossref","first-page":"e60352","DOI":"10.1371\/journal.pone.0060352","article-title":"Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2014.11.001_bb0445","first-page":"1379","article-title":"Eculizumab in atypical hemolytic\u2013uremic syndrome","volume":"369","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0450","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","article-title":"Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy","volume":"191","author":"Tati","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2014.11.001_bb0455","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"Reti","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2014.11.001_bb0460","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.11.001_bb0465","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2014.11.001_bb0470","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0475","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0480","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case\u2013control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2014.11.001_bb0485","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic\u2013uraemic syndrome: an analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0490","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0495","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.blre.2014.11.001_bb0500","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3109\/14767058.2012.694923","article-title":"The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome","volume":"25","author":"Crovetto","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0505","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/0009922811412942","article-title":"Atypical hemolytic\u2013uremic syndrome in a child presenting with malignant hypertension","volume":"52","author":"Totina","year":"2013","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.blre.2014.11.001_bb0510","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MOT.0000000000000074","article-title":"Thrombotic microangiopathy in renal allografts: the diagnostic challenge","volume":"19","author":"Nadasdy","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0515","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0520","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bbmt.2012.12.012","article-title":"Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation","volume":"19","author":"Rajpal","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0525","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0530","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2014.11.001_bb0535","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2004.10.018","article-title":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15","volume":"45","author":"Licht","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.blre.2014.11.001_bb0540","first-page":"72","article-title":"Successful treatment of transplant-associated microangiopathy with rituximab","volume":"122","author":"Marr","year":"2009","journal-title":"N Z Med J"},{"key":"10.1016\/j.blre.2014.11.001_bb0545","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/bmt.2008.25","article-title":"Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura","volume":"41","author":"Carella","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0550","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.11.001_bb0555","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1111\/j.1399-3046.2010.01408.x","article-title":"Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation","volume":"16","author":"Jodele","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0560","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.blre.2014.11.001_bb0565","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jca.20216","article-title":"Thrombotic microangiopathy during peripheral blood stem cell mobilization","volume":"24","author":"Naina","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.blre.2014.11.001_bb0570","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0049-3848(00)00256-5","article-title":"Protective effect of defibrotide on perfusion induced endothelial damage","volume":"99","author":"San","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2014.11.001_bb0575","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.2042-7158.1995.tb05789.x","article-title":"Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity","volume":"47","author":"Schroder","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.blre.2014.11.001_bb0580","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.transproceed.2007.01.075","article-title":"Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience","volume":"39","author":"Sucak","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.blre.2014.11.001_bb0585","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0590","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","article-title":"Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus\u2013sirolimus on endothelial cells: protective effect of defibrotide","volume":"19","author":"Carmona","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0595","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.11.001_bb0600","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bmt.1702648","article-title":"Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation","volume":"26","author":"Uderzo","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0605","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0610","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0615","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic\u2013uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0620","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: diagnosis and pathogenesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.blre.2014.11.001_bb0625","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ndt\/gfs336","article-title":"Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury","volume":"28","author":"Kurniati","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0630","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm0206-171","article-title":"Angiogenesis and inflammation face off","volume":"12","author":"Imhof","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0635","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bbmt.2014.04.030","article-title":"Predictive value of circulating angiopoietin-2 for endothelial damage \u2014 related complications in allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Ueda","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0640","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.11.001_bb0645","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"Wuhl","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.11.001_bb0650","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1160\/TH10-02-0138","article-title":"Removal of elevated circulating angiopoietin-2 by plasma exchange \u2014 a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease","volume":"104","author":"Lovric","year":"2010","journal-title":"Thromb Haemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T05:54:52Z","timestamp":1598507692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X14000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0268960X14000988"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.11.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}